Creative Diagnostics now can provide recombinant SARS-CoV-2 RBD mutants expressed in HEK293 cells. Some of these antigens have higher affinity to human ACE2.
Creative Diagnostics now can provide matched antigen pair of SARS-CoV-2 spike/RBD. These antigens have been validated for SARS-CoV-2 total antibodies detection in double-antigen sandwich immunoassay.
This cell line is constructed by transduction of human angiotensin I converting enzyme 2 (ACE2) into HEK293T cells, followed by stable cell selection. HEK293T is derived from HEK293 and is commonly used in scientific research.
Creative Diagnostics now offers immunoassay kits for direct detection of the new coronavirus and antibodies against SARS-CoV-2
SARS coronavirus, also known as SARS-CoV, emerged in the human population in Guangdong province of southeastern, China in 2002, Within months, the outbreak had spread to 29 countries and regions causing over 8000 human cases and almost 800 deaths in the 2002-2003 outbreak.
The Middle East respiratory syndrome-related coronavirus, also known as MERS-CoV, which was first reported in Saudi Arabia in 2012. MERS-CoV is a zoonotic virus, which means it is a virus that is transmitted between animals and people.
Coronaviruses are named for the crown-like spikes on their surface. Human coronaviruses (HCoVs) are enveloped, single-stranded, positive-sense RNA viruses that belong to the coronaviridae family.
Creative Diagnostics now can provide recombinant 2019-nCoV antigens. These antigens can be used for scientific research, detection of novel coronavirus and preparation of neutralizing antibodies.
Creative Diagnostics is proud to offer Africa swine fever virus antigens and antibodies. These antigens and antibodies have been validated to work in various types of immunoassays and can be supplied as high quality tools for ASFV detection.
Creative Diagnostics has established a global-leading Hepatitis B Virus Surface Antigen Mutants manufacture platform using Yeast expression system. With years of exploration, different highly purified HBsAg/their mutants were obtained.
Creative Diagnostics is proud to offer a series of Nanobodies/VHHs that bind to primary antibodies with high affinity and specificity. Currently, Nano Secondary Antibodies against rabbit and mouse IgG are available.
Creative Diagnostics is proud to offer a large range of foodborne pathogen antigens and antibodies. These antigens and antibodies have been validated to work in various types of immunoassays and can be supplied as high quality tools for the detection foodborne pathogens.
Creative Diagnostics is proud to launch its new line of products to advance veterinary science research. These antibodies will greatly facilitate studies involving animal health, veterinary disease model and diagnostics development, animal welfare and reproduction, food security, public health, and emerging infectious diseases.
Creative Diagnostics offers several new ELISA Kits for quantitative and qualitative analysis of drugs residues in different kinds of samples. Our ELISA product line covers various drug residues. In addition, the test sensitivity of our kits is far below the maximum residue limit (MRL), which is a secure choice for multiple purposes.
To allow sensitive measurement of PEGylated compounds, Creative Diagnostics have produced a set of specific anti-PEG monoclonal antibodies. These antibodies have been validated to work in various types of immunoassays and can be supplied as high quality research tools to develop sensitive and specific assays.
Creative Diagnostics offers monoclonal and polyclonal antibodies against different categories of cytotoxic drug: Tubulin Inhibitor; DNA Damaging; RNA Polymerase II and III Inhibitor; DNA Topoisomerase I Inhibitor and DNA Inhibitor.
Creative Diagnostics is providing high sensitivity ELISA kits for peptide drugs detection. These kits are used for detecting drug residues in serum and plasma and have been widely used in vitro pharmacokinetics testing in drug development processes and research.
Creative Diagnostics provides highly sensitive small molecule drug antibodies and paired conjugates for small molecule drugs and metabolites immunoassay detection kit development.
Creative Diagnostics has established a global-leading virus-like particles (VLPs) manufacture platform using E. coli cell system. With years of exploration, our scientists have successfully obtained various highly purified HPV VLPs. Our products have significantly contributed to the HPV vaccine related research.
Creative Diagnostics now offers a newly developed set of humanized monoclonal antibodies (IgM, IgG or IgA) that can be used as calibrators, positive, negative or quality controls in assay development and manufacturing of diagnostic kits.